Bio Farma Targets Production of 186 Million Doses of COVID-19 Vaccine in 2021

PT Bio Farma (Persero) targets COVID-19 vaccine production to reach 186.1 million doses by the end of 2021. As of June 2021, Bio Farma had produced 59.7 million doses of the vaccine, using raw materials from Sinovac. This amounts to 31% of Bio Farma's vaccine production target.

Bio Farma will produce another 16.6 million doses of the corona vaccine in July 2021. Vaccine production will then be increased to reach 20 million doses in September 2021. The largest estimated production is 24.9 million doses in October 2021.

Simultaneously, the supply of raw materials for the corona vaccine will continue to arrive until November 2021. [Source name - presumably Honesti, needs clarification in original text] stated that raw materials for the vaccine will reach 286 million doses throughout this year.

As of July 7, 2021, Bio Farma has distributed 52.8 million doses of the corona vaccine. This is equivalent to 82.5% of the total 64 million doses of corona vaccine distributed.

Of the distributed vaccines, 8.2 million doses were AstraZeneca production, and 3 million doses were finished products from Sinovac.

Although the vaccination program is underway, the public is urged to remain disciplined in implementing the 3M health protocols to prevent corona. These health protocols include wearing masks, maintaining distance, and washing hands with soap.